Orthofix International (NASDAQ:OFIX) updated its FY18 earnings guidance on Monday. The company provided EPS guidance of $1.76-1.84 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.83. The company issued revenue guidance of $450-455 million, compared to the consensus revenue estimate of $452.35 million.
Several brokerages have recently issued reports on OFIX. BidaskClub downgraded shares of Orthofix International from a hold rating to a sell rating in a research note on Thursday, February 15th. Zacks Investment Research upgraded shares of Orthofix International from a hold rating to a buy rating and set a $60.00 price objective on the stock in a research note on Thursday, November 2nd. Finally, TheStreet downgraded shares of Orthofix International from a b rating to a c+ rating in a research note on Tuesday, October 31st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $54.42.
Shares of Orthofix International (NASDAQ:OFIX) opened at $57.14 on Wednesday. The stock has a market cap of $999.24, a price-to-earnings ratio of 173.16, a PEG ratio of 2.38 and a beta of 0.22. Orthofix International has a 52 week low of $33.90 and a 52 week high of $59.25.
In other Orthofix International news, insider Bradley V. Niemann sold 5,547 shares of Orthofix International stock in a transaction on Monday, December 11th. The shares were sold at an average price of $52.08, for a total transaction of $288,887.76. Following the sale, the insider now owns 34,631 shares in the company, valued at $1,803,582.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 5.60% of the stock is owned by insiders.
WARNING: “Orthofix International (OFIX) Issues FY18 Earnings Guidance” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3228693/orthofix-international-ofix-issues-fy18-earnings-guidance.html.
Orthofix International Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.